None listed
Conditions
Interventions
Twenty-eight male volunteers were sub-divided in three groups: ten presented chronic obstructive pulmonary disease (COPD – 69+/-9 years); nine presented chronic heart failure (CHF - 62+/-8 years) and; nine were healthy with 64+/-5 year-old (control). During all experimental protocol, the subjects were monitored at the chest-manubrio lead (MC5) to record the heart rate (HR) beat-to-beat. The ECG and HR were obtained from a one-channel heart monitor (TC 500, ECAFIX, Sao Paulo, SP, Brazil) and processed using an analog-digital converter Lab. PC+ (National Instruments, Co.,Austin, TX, USA), which represents an interface between the heart monitor and a Pentium III microcomputer. The signals were recorded in real time after analog to digital conversion on a beat-to-beat basis using specific software. The three groups’ the electrocardiography signal were obtained on the following conditions: 1) supine position for 15 min; and 2) supine position during the respiratory sinusal arrhythmia (M-RSA)for 4 min. The data were analyzed by the time and the frequency domain. Regarding the M-RSA indexes, the expiratory/inspiratory ratio (E/I) and the inspiratory/expiratory difference (IE difference) were calculated. All evaluations were performed on the same day.
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria for COPD patients were: forced expiratory volume in one second (FEV1) / forced vital capacity (FVC) ratio < 0.7 and FEV1 < 60% of predicted; clinical stability for at least 3 months prior to the study; nonsmokers; no participation in a regular physically active program in for the last 6 months; and presentation of dyspnea under low and medium physical effort. Inclusion criteria for CHF patients were: previous history of stable symptomatic heart failure due to left ventricular systolic dysfunction, documented in at least six months (left ventricular ejection fraction < 45 % predict); no recent hospitalizations and no history of pulmonary disease or angina. Subjects in the control group were free of chronic pulmonary, cardiovascular, immune, and metabolic disease.
Exclusion criteria
unstable patients, female, patients without clinical exams